e.l.f. Beauty, Inc. ELF

Healthcare SIC 2844 - Perfumes, Cosmetics & Other Toilet Preparations NYSE

e.l.f. Beauty, Inc. ("e.l.f. Beauty" and together with our subsidiaries, the "Company," or "we") is a multi-brand beauty company that offers inclusive, accessible, clean, vegan and cruelty free cosmetics and skin care products.

•Our Vision. To be a different kind of beauty company by building brands that disrupt industry norms, shape culture and connect communities through positivity, inclusivity and accessibility.

•Our Mission. We make the best of beauty accessible to every eye, lip and face.

•Our Purpose. We make the world a better place for every eye, lip and face.

Last close 109.67 2026-09-04
Market cap $6.47B 2026-06-30 share count
52-week range 48.82 - 150.99

Valuation FY2025 figures against the last close

P/S4.0x
P/E249.2x
P/FCF34.0x
EV/EBITDA45.9x
Dividend yield
Diluted EPS0.44

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $1.64B$1.31B$1.02B$578.8M$392.2M$318.1M$282.9M$267.4M$269.9M$229.6M
Cost of revenue $479.1M$377.8M$299.8M$188.4M$140.4M$111.9M$101.7M$104.7M$105.2M$97.3M
Gross profit $1.16B$935.7M$724.1M$390.4M$251.7M$206.2M$181.1M$162.7M$164.7M$132.2M
SG&A $1.03B$777.7M$574.4M$322.3M$221.9M$194.2M$157.2M$136.6M$131.4M$109.2M
Operating income $73.6M$158.0M$149.7M$68.1M$29.8M$9.4M$29.9M$26.2M$33.3M$23.1M
Interest expense $7.0M$2.0M$2.4M$4.1M$6.3M$7.8M$8.8M$16.3M
Pre-tax income $40.5M$145.5M$141.0M$64.1M$25.4M$3.7M$24.1M$18.0M$22.5M$9.8M
Income tax $14.1M$33.4M$13.3M$2.5M$3.7M$2.5M$6.2M$2.4M$11.0M$4.5M
Net income $26.3M$112.1M$127.7M$61.5M$21.8M$6.2M$17.9M$15.5M$33.5M$5.3M
EPS, basic 0.451.992.331.170.430.130.370.330.74-39.47
EPS, diluted 0.441.922.211.110.410.120.350.320.68-39.47
Shares, diluted (wtd. avg.) $59.4M$58.3M$57.8M$55.3M$53.7M$52.0M$50.8M$49.3M$49.4M$12.6M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $289.7M$148.7M$108.2M$120.8M$43.4M$57.8M$46.2M$53.9M$10.1M$15.3M
Receivables $174.6M$126.0M$123.8M$67.9M$45.6M$40.2M$29.7M$36.7M$44.6M$37.8M
Inventory $220.2M$187.2M$191.5M$81.3M$84.5M$56.8M$46.2M$46.3M$62.7M$69.4M
Total current assets $789.4M$540.6M$477.1M$303.3M$193.0M$170.1M$132.4M$141.7M$123.6M$124.9M
Property, plant and equipment $41.5M$28.8M$14.0M$7.9M$10.6M$13.8M$17.2M$21.8M$18.0M$17.2M
Goodwill $853.5M$340.6M$340.6M$171.6M$171.6M$171.6M$171.3M$157.3M$157.3M$157.3M
Other intangibles $553.1M$207.7M$225.1M$78.0M$86.2M$94.3M$102.4M$98.8M$105.9M$113.0M
Total assets $2.39B$1.25B$1.13B$595.6M$494.6M$487.4M$453.1M$435.9M$417.2M$414.7M
Accounts payable $97.5M$72.2M$81.1M$31.4M$19.2M$15.7M$12.4M$20.5M$26.8M$37.9M
Total current liabilities $336.2M$177.1M$299.1M$108.0M$65.0M$73.3M$51.1M$43.0M$51.4M$80.3M
Long-term debt $841.7M
Total liabilities $1.26B$487.3M$486.7M$184.6M$182.2M$217.7M$210.9M$206.5M$223.4M$273.9M
Retained earnings -$155.9M-$182.2M-$294.3M-$422.0M-$483.5M-$505.3M-$511.5M-$511.5M-$527.0M-$560.4M
Total equity $1.13B$760.9M$642.6M$411.0M$312.4M$269.6M$242.2M$215.2M$193.9M$140.9M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $212.5M$133.8M$71.2M$101.9M$19.5M$29.5M$44.3M$55.6M$12.4M$2.1M
Depreciation and amortisation $79.4M$44.1M$30.2M$17.6M$27.1M$25.2M$22.8M$17.9M$14.5M$13.2M
Stock-based compensation $86.9M$71.8M$40.6M$29.1M$19.6M$19.7M$15.5M$16.8M$13.5M$7.1M
Capital expenditure $22.4M$18.5M$8.7M$1.7M$4.8M$6.5M$9.4M$8.9M$7.5M$9.2M
Investing cash flow -$605.2M-$19.1M-$284.7M-$1.7M-$4.8M-$6.5M-$35.3M-$8.9M-$10.4M-$9.1M
Financing cash flow $533.9M-$74.4M$200.9M-$22.7M-$29.1M-$11.4M-$16.7M-$5.6M-$7.2M$8.3M
Buybacks $50.0M$67.1M$0$0$0$0$7.9M$0$0

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001600033-26-000030.

Others in SIC 2844

TickerCompanyMarket capP/ERevenue growth
CL COLGATE PALMOLIVE CO $70.77B 33.8x 1.4%
EL ESTEE LAUDER COMPANIES INC $37.63B 207.7x 5.0%
KVUE Kenvue Inc. $36.00B 24.7x -2.1%
IPAR INTERPARFUMS INC $3.74B 22.3x 2.5%
COTY COTY INC. $2.58B -1.5%
EPC EDGEWELL PERSONAL CARE Co $1.33B 54.5x -1.3%
WALD Waldencast plc $156.3M -0.7%
SLSN SOLESENCE, INC. $60.0M 42.5x 18.6%